June 6, 2023 01:21 PM EDTUpdated 01:57 PM
Pharma

Mer­ck­'s CMV drug is ap­proved for kid­ney trans­plant pa­tients

Katherine Lewin

News Reporter

Mer­ck grabbed an­oth­er in­di­ca­tion for its cy­tomegalovirus (CMV) treat­ment Pre­vymis — this time to pre­vent CMV dis­ease in adult kid­ney trans­plant re­cip­i­ents …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

The End­points 100: The biotech in­dus­try braces for Trump 2.0

Dur­ing Covid, RFK Jr. lob­bied against vac­cine EUAs for chil­dren. As HHS sec­re­tary, he could re­scind them

Drugs are ap­proved — and made avail­able — faster in US than most of EU, da­ta show

Lil­ly’s oral SERD makes strides in breast can­cer with Phase 3 da­ta

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times